|
Post by johank on Dec 7, 2015 14:46:37 GMT
Some of the best bounces are misunderstood news, stocks that have history of fading. Wonder how far this could go if it really did start ripping. Watch for breakout if it starts trading over $2.10. This could move to the $3-$4ish range over the next month as everyone understands the implications. It was trading in that range and heading even higher earlier this year before they announced the Phase 2 results. But, Jck, big gap to fill from this morning. Do you see it filling prior to $3-4?
|
|
|
Post by jckrdu on Dec 7, 2015 14:59:59 GMT
Watch for breakout if it starts trading over $2.10. This could move to the $3-$4ish range over the next month as everyone understands the implications. It was trading in that range and heading even higher earlier this year before they announced the Phase 2 results. But, Jck, big gap to fill from this morning. Do you see it filling prior to $3-4? Maybe, maybe not.
Today's news was pretty big IMO, and is the type of news where stocks run and don't fill lower gaps. The $1.54 close was near the 1 year low. With positive Phase 2 data announced, it could easily run and not look back. I added a bit more at $1.79 and have more cash available if it pulls back further, but I want to have a decent sized position in case this runs over $2 and doesn't look back.
|
|
|
Post by Yelk on Dec 7, 2015 15:28:50 GMT
Bit disappointed with action so far. I guess one never knows, could go later today or long term. I wonder if people selling because rehash of November 5 press release. My stop is mid 1.60s. Would only add if volume increases of sentiment changes. It does seem majority of data was already known November.
|
|
|
Post by johank on Dec 7, 2015 15:46:08 GMT
But, Jck, big gap to fill from this morning. Do you see it filling prior to $3-4? Maybe, maybe not.
Today's news was pretty big IMO, and is the type of news where stocks run and don't fill lower gaps. The $1.54 close was near the 1 year low. With positive Phase 2 data announced, it could easily run and not look back. I added a bit more at $1.79 and have more cash available if it pulls back further, but I want to have a decent sized position in case this runs over $2 and doesn't look back.
Thanks, I added more last Friday, but added a bit more today on the dips to 1.75 just now. I have a small position.
|
|
|
Post by jckrdu on Dec 7, 2015 15:53:25 GMT
Bit disappointed with action so far. I guess one never knows, could go later today or long term. I wonder if people selling because rehash of November 5 press release. My stop is mid 1.60s. Would only add if volume increases of sentiment changes. It does seem majority of data was already known November. News toady wasn't a rehash - New information today is 14.3 months (and counting) OS, and that they will move on to a Phase 3 study.
IMO, today's action is a bit of a "sell the news" effect, and the market now looking ahead to how Phase 3 will get funded. IMO, with solid data now in-hand, MEIP is in the drivers seat to structure a partnership on favorable terms to execute Phase 3. If they go it alone, they should be able to raise cash without too much of a discount.
IMO, this will move higher, but a big move may not happen until Phase 3 funding becomes clear. For now, some traders may see this morning's gap and have decided to sell.
I added and will hold as we should see some analyst upgrades in the coming days/weeks.
Also could see some institutional buying surface in the days/weeks/months ahead as the longer term picture looks promising.
|
|
|
Post by harleyquinn on Dec 7, 2015 16:13:43 GMT
I added a bit too. May not run much further but felt pretty comfortable adding some here.
|
|
|
Post by Macgruber on Dec 7, 2015 17:42:57 GMT
Bit disappointed with action so far. I guess one never knows, could go later today or long term. I wonder if people selling because rehash of November 5 press release. My stop is mid 1.60s. Would only add if volume increases of sentiment changes. It does seem majority of data was already known November. News toady wasn't a rehash - New information today is 14.3 months (and counting) OS, and that they will move on to a Phase 3 study.
IMO, today's action is a bit of a "sell the news" effect, and the market now looking ahead to how Phase 3 will get funded. IMO, with solid data now in-hand, MEIP is in the drivers seat to structure a partnership on favorable terms to execute Phase 3. If they go it alone, they should be able to raise cash without too much of a discount.
IMO, this will move higher, but a big move may not happen until Phase 3 funding becomes clear. For now, some traders may see this morning's gap and have decided to sell.
I added and will hold as we should see some analyst upgrades in the coming days/weeks.
Also could see some institutional buying surface in the days/weeks/months ahead as the longer term picture looks promising.
Thanks for the input jckrdu. News was not a rehash today and there is still more to come on MDS as I'm sure you already know. There are way too many careless ppl in this stock as a result of pumping which is why imo it was going to be a sell the news scenario today. The day isnt over yet and it could turn around at any point though. This is going to be a great investment at the current sp going into Q1. I am adding at the moment. GL everyone
|
|
|
Post by Yelk on Dec 7, 2015 21:06:09 GMT
I got out mid .70s small loss today. I think you guys have something here though. Just crowded misinformed shorts, gap sellers and panic sellers. Also typical fader stock. Let it wash out and start to rebuild of this news. Mine was a shorter term plan and it didn't pan out. Best of luck here! Best time to buy a stock is when nobody wants it!
|
|
|
Post by johank on Dec 7, 2015 21:31:42 GMT
Bit disappointed with action so far. I guess one never knows, could go later today or long term. I wonder if people selling because rehash of November 5 press release. My stop is mid 1.60s. Would only add if volume increases of sentiment changes. It does seem majority of data was already known November. News toady wasn't a rehash - New information today is 14.3 months (and counting) OS, and that they will move on to a Phase 3 study.
IMO, today's action is a bit of a "sell the news" effect, and the market now looking ahead to how Phase 3 will get funded. IMO, with solid data now in-hand, MEIP is in the drivers seat to structure a partnership on favorable terms to execute Phase 3. If they go it alone, they should be able to raise cash without too much of a discount.
IMO, this will move higher, but a big move may not happen until Phase 3 funding becomes clear. For now, some traders may see this morning's gap and have decided to sell.
I added and will hold as we should see some analyst upgrades in the coming days/weeks.
Also could see some institutional buying surface in the days/weeks/months ahead as the longer term picture looks promising.
|
|
|
Post by Macgruber on Dec 8, 2015 15:45:40 GMT
Trading nicely today
|
|
|
Post by jckrdu on Dec 9, 2015 15:10:34 GMT
Been adding in the $1.60s and low $1.70s the past 2 days.
|
|
|
Post by jckrdu on Dec 9, 2015 17:26:35 GMT
But, Jck, big gap to fill from this morning. Do you see it filling prior to $3-4? Maybe, maybe not.
Today's news was pretty big IMO, and is the type of news where stocks run and don't fill lower gaps. The $1.54 close was near the 1 year low. With positive Phase 2 data announced, it could easily run and not look back. I added a bit more at $1.79 and have more cash available if it pulls back further, but I want to have a decent sized position in case this runs over $2 and doesn't look back.
Coming back to this post from johank...
So that gap almost filled but not quite... there's still a tiny gap from $1.54 to $1.56. Will that remaining gap fill before moving higher? Who knows.
Per my prior post, I've added in the low $1.70s and high $1.60s as I like the view from 10,000 feet which is - MEIP just released very positive Phase 2 results, announced their intent to move into Phase 3, and the current pps has MEIP trading at a little more than the cash they have on the balance sheet.... which is essentially valuing the pipeline at $0.
IMO, more buyers will surface in the days/weeks/months ahead.
|
|
|
Post by johank on Dec 9, 2015 18:24:57 GMT
Slowly adding some more. Agree with Jck, trading at cash with intentions towards P3 looks really nice. I must say, after my experience of the slow drip, drip, drip from OCAT, it's refreshing to be invested in a company that is actually going into a P3 trial!! First time for me!
|
|
|
Post by ignorantsilver on Dec 11, 2015 23:53:04 GMT
Same here, accumulating whenever I can. I like their new chairwoman of the board good choice.
|
|
|
Post by virginiagina on Dec 21, 2015 16:26:31 GMT
Yes, it's nice to see a biotech that gives a leadership role to a woman. I know this is a bit sexist, but I trust a woman to safeguard my money and investment a lot more than a man. I feel a lot of men run these companies to their own enrichment rather than shareholders or society. I am thrilled with the choice of Christine White. Take that glass ceiling!
Ginny
|
|
|
Post by JHam on Dec 21, 2015 20:58:25 GMT
Yes, it's nice to see a biotech that gives a leadership role to a woman. I know this is a bit sexist, but I trust a woman to safeguard my money and investment a lot more than a man. I feel a lot of men run these companies to their own enrichment rather than shareholders or society. I am thrilled with the choice of Christine White. Take that glass ceiling! Ginny Nice try Ignorantsilver. It is pretty easy to spot you. Continue joining and I'll continue banning you.
JHam
|
|
|
Post by danasa52 on Dec 31, 2015 13:29:45 GMT
|
|
|
Post by Yelk on Jan 8, 2016 20:36:37 GMT
Is there something I don't know like some bad warrant build or something? Seems like its going to make fresh all time lows shortly. Obviously markets have pulled back but seems like bottom not in here yet. I think this stock is very undervalued.
|
|
|
Post by Macgruber on Jan 11, 2016 19:53:48 GMT
Building back up a position here. Valuation just makes no sense at all to me. Trading probably 5-6 million under cash right now. Will add in 10c increments as it drifts lower on no news. Need some kind of pr here
|
|
|
Post by Macgruber on Jan 21, 2016 19:17:44 GMT
Plan still to begin ph 3 registration in the 2nd half of 2016. Check the latest presentation with data from ash and further guidance if you aren't familiar with this company. Am I crazy to think partnership on AML is still in the works here? See Celgenes most recent 10q and look at the sales in Vidaza. Why wouldn't they have any interest in Pracinostat? Data is far superior to Vidaza at this point and still maturing. Could they be waiting to strike a deal until median os is reached? Data was just presented a month ago, don't deals take time? I feel like everyone is jumping ship right now based on current market conditions and fear of capital raise, neither of which seem logical to me. Anyway looks like events were updated on the website, they are presenting at the BIO CEO & investor conf Feb 8th. Maybe we hear something good investor.meipharma.com/events-webcasts
|
|